Literature DB >> 14656691

Serum interleukin-18 and nitric oxide activity in bladder carcinoma.

Neslihan Bukan1, Sinan Sözen, Ugur Coskun, Banu Sancak, Nazan Günel, Ibrahim Bozkirli, Cagri Senocak.   

Abstract

BACKGROUND: Both interleukin-18 and nitric oxide are multifunctional molecules that are involved in the different steps of carcinogenesis.
METHODS: In the present study, we measured serum interleukin-18 and nitric oxide activity in 51 bladder cancer patients with different tumor stage and grade, and in 8 healthy controls. Serum nitrite-nitrate levels were measured as an index of nitric oxide generation.
RESULTS: Serum interleukin-18 levels were significantly higher in bladder cancer patients when compared to the control subjects (p > 0.05). Serum interleukin-18 levels were found to be higher in patients with Ta stage than patients with T1 and T2, T3, T4 stages and in patients with grade 1 tumors than patients with grade 2 and grade 3 tumors, but this was not statistically significant (p > 0.05). There was no significant difference in serum nitrite + nitrate levels between bladder cancer patients and control subjects.
CONCLUSIONS: Elevated serum interleukin-18 levels in bladder carcinoma patients may be a result of host defence mechanism against the growth and progression of bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656691

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  5 in total

1.  Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.

Authors:  Zahra Mojtahedi; Bijan Khademi; Seyed Basir Hashemi; Seyed Mohammad Bagher Abtahi; Mohammad Ali Ghasemi; Mohammad Javad Fattahi; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2010-03-27       Impact factor: 3.201

2.  The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.

Authors:  İlhan Gecit; Recep Eryılmaz; Servet Kavak; İsmail Meral; Halit Demir; Necip Pirinççi; Mustafa Güneş; Kerem Taken
Journal:  J Membr Biol       Date:  2017-08-16       Impact factor: 1.843

3.  Chronic inflammation in urothelial bladder cancer.

Authors:  Gabriella Nesi; Stefania Nobili; Tommaso Cai; Saverio Caini; Raffaella Santi
Journal:  Virchows Arch       Date:  2015-08-12       Impact factor: 4.064

4.  Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.

Authors:  Ilhan Gecit; Mehmet Aslan; Mustafa Gunes; Necip Pirincci; Ramazan Esen; Halit Demir; Kadir Ceylan
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-19       Impact factor: 4.553

5.  A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong; Lei Yin
Journal:  BMC Cancer       Date:  2021-07-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.